Key Insights

Highlights

Treatment Research

5 treatments under study, led by Irinotecan

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2/3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Irinotecan1
  • Docetaxel1
  • 5fu1
  • Oxaliplatin1
  • Leucovorin1

Active Sponsors

  • Blokhin's Russian Cancer Research Center1

Top Investigators

Related Conditions

  • Oxaliplatin1
  • Stomach Neoplasms1
  • Docetaxel1
  • Gastrointestinal Neoplasms1
  • Irinotecan Hydrochloride1

Activity Timeline